374223005: Cabergoline 0.5mg tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1199524016 Cabergoline 0.5mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1212657018 Cabergoline 0.5mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1199524016 Cabergoline 0.5mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1199524016 Cabergoline 0.5mg tablet (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1212657018 Cabergoline 0.5mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1212657018 Cabergoline 0.5mg tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cabergoline 0.5mg tablet	Is a	Ergoline derivative-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet	Is a	Dopamine agonist	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet	Is a	Cabergoline-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Central nervous system agent (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Cabergoline	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Cabergoline 0.5mg tablet	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

SAME AS association reference set (foundation metadata concept)